MindMed (MMED) issues a material disclosure — pipeline update, financing, or partnership — within 6 weeks explaining today's divergent 4.7% move.

MindMed (ticker: MMED) is a publicly traded psychedelic drug company whose stock recently jumped about 4.7% on a day when most similar stocks fell — a pattern that often signals that people with inside knowledge are buying ahead of news. Within the next six weeks, the company is expected to announce something significant, such as an update on its drug pipeline, a new funding deal, or a business partnership. This kind of unusual stock movement rarely happens by accident.

Single-name outperformance on a down sector day signals informed flow. Catalysts, not narrative, move these tickers. I trade the disclosure gap.